Israel - hebreu - Ministry of Health

david margalit & co.ltd - ciprofloxacin as hydrochloride 500 mg - tablets - fluoroquinolones - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.

Israel - hebreu - Ministry of Health

abic veterinary products ltd - enrofloxacin - תמיסה - enrofloxacin 100 mg/ml

Israel - hebreu - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

Israel - hebreu - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 20 mg/ml - ibuprofen

Israel - hebreu - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

Israel - hebreu - Ministry of Health

sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.

Israel - hebreu - Ministry of Health

cts chemical industries ltd, israel - calcium carbonate - טבליות לעיסות - calcium carbonate 500 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

Israel - hebreu - Ministry of Health

cts chemical industries ltd, israel - calcium as carbonate - טבליות לעיסות - calcium as carbonate 500 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

Israel - hebreu - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Israel - hebreu - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.